BIOMAT Database Logo BIOMAT Database Logo

[Possibilities of the clinical use of a purified fraction of Agkistrodon rhodostoma venom in anticoagulant therapy]. 1974

A Isidori, and I Fischetti, and S Pallotta, and C Piro

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002542 Intracranial Embolism and Thrombosis Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures. Brain Embolism and Thrombosis,Cerebral Embolism and Thrombosis,Embolism and Thrombosis, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Isidori, and I Fischetti, and S Pallotta, and C Piro
[Anticoagulant activity of Agkistrodon rhodostoma venom].
December 1974, La Clinica terapeutica,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
[Activity against clotting and platelet aggregation of the anticoagulant fraction of venom from Agkistrodon rhodostoma].
October 1975, La Clinica terapeutica,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
Studies on type specific immunity to the whole venom and a fraction of Agkistrodon rhodostoma.
January 1971, Research communications in chemical pathology and pharmacology,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
Anticoagulant therapy with a purified fraction of Malayan pit viper venom.
March 1968, Lancet (London, England),
A Isidori, and I Fischetti, and S Pallotta, and C Piro
Studies on the active site of IRC-50 arvin, the purified coagulant enzyme from Agkistrodon rhodostoma venom.
April 1972, European journal of biochemistry,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
A novel alpha-type fibrinogenase from Agkistrodon rhodostoma snake venom.
December 1992, Biochimica et biophysica acta,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
[Experimental analysis of the effects of the anticoagulant fraction of Agkistrodon rhodostoma venom on the heart, the vascular and respiratory systems and on certain muscles].
October 1975, Minerva cardioangiologica,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
The effect of the purified anticoagulant principle of Agkistrodon acutus venom on blood coagulation.
April 1973, Toxicon : official journal of the International Society on Toxinology,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I.
July 1966, The Journal of clinical investigation,
A Isidori, and I Fischetti, and S Pallotta, and C Piro
alpha-Fibrinogenase from Agkistrodon rhodostoma (Malayan pit viper) snake venom.
January 1983, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!